NOVASENTA
Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. The company aims to identify novel targets to generate effective therapies for various cancers. It was founded in 2018 and is headquartered in Pittsburgh, Pennsylvania.
NOVASENTA
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Therapeutics
Founded:
2018-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.novasenta.com
Status:
Active
Contact:
412-621-6200
Email Addresses:
[email protected]
Total Funding:
40 M USD
Current Advisors List
Current Employees Featured
Founder
Investors List
UPMC Enterprises
UPMC Enterprises investment in Series A - Novasenta
Official Site Inspections
http://www.novasenta.com Semrush global rank: 3.28 M Semrush visits lastest month: 4.99 K
- Host name: dp-2c7b640c44.dreamhostps.com
- IP address: 69.163.214.215
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Novasenta"
Home - Novasenta
Exploiting the interplay between. disease and immunity. to cure cancerSee details»
About - Novasenta
Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from …See details»
Novasenta - Crunchbase Company Profile & Funding
Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, …See details»
Novasenta - Org Chart, Teams, Culture & Jobs - The Org
Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable …See details»
Novasenta - LinkedIn
Novasenta is a UPMC Enterprises portfolio company that discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with...See details»
Novasenta Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Novasenta. Use the PitchBook Platform to explore the full profile.See details»
David Moore - Novasenta
David (Dave) Moore has served as the Chairman of the Board of Directors of Novasenta since mid-2023. Dave brings over 20 years of biopharma operational and executive management …See details»
Novasenta Company Profile - Office Locations, Competitors, …
Novasenta is a biotechnology company focused on developing treatments for patients with cancer. It offers a platform for single-cell level analysis, and human tumor samples combined …See details»
Novasenta - BIO International Convention | BIO - bio.org
Novasenta is focused on the discovery of novel therapeutic targets to develop innovative and effective treatments for cancer patients. The company has developed a proprietary platform for …See details»
UPMC Launches Novasenta to Develop Targeted Immunotherapy …
PITTSBURGH, Aug. 24, 2021 /PRNewswire/ -- As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched …See details»
UPMC Launches Novasenta to Develop Targeted …
Aug 23, 2021 · As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery and development company seeking novel and effective …See details»
Our Science & Pipeline - Novasenta
Novasenta’s discovery process is patient-centric with a focus on in-depth analysis of high-quality samples from human tumors. We comprehensively map the tumor microenvironment and …See details»
UPMC Launches Drug Discovery Company Novasenta to Develop …
Aug 23, 2021 · UPMC today announced the launch of Novasenta, a drug discovery and development company seeking novel and effective treatments for cancerSee details»
Novasenta Completes $40 million Series A to Advance Novel …
PITTSBURGH, July 29, 2022 /PRNewswire/ -- Novasenta Inc., a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, today …See details»
UPMC Launches Novasenta to Develop Targeted Immunotherapy …
PITTSBURGH, Aug. 23, 2021 – As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery …See details»
Novasenta closes $40 million Series A funding round
Jul 29, 2022 · UPMC Enterprises portfolio company Novasenta recently announced the completion of $40 million in Series A financing. The funding from UPMC Enterprises will allow …See details»
Novasenta - BIO CEO & Investor Conference | BIO
Feb 6, 2023 · Novasenta is focused on the discovery of novel therapeutic targets to develop innovative and effective treatments for cancer patients. The company has developed a …See details»
Press Releases - Novasenta
Jul 29, 2022 · Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics //See details»